Press ReleasesKanabo Group Set To Advise On Developing Industry Standards...

Kanabo Group Set To Advise On Developing Industry Standards For CBD Vape Products

-

PRESS RELEASE

PIONEERING medical cannabis company Kanabo Group has been selected as a steering group member for the development of a British Standard for CBD non-tobacco Vape products. CBD Vape products provide an alternative method to consuming CBD, which has been dominated by food and cosmetic products.

Standardisation of the category is currently minimal and has historically focused on the safety of electronic components of CBD Vape products. The British Standards Institution (BSI) has announced a Publicly Available Specifications (PAS) expected to be published in early 2023 for CBD Vape Products to develop a standard specification for their safety, quality and performance, which will ensure consumer protection while driving category growth. 

PAS is a sponsored standardisation document compiled and co-developed by industry experts and stakeholders, defining best practice with the goal of introducing standardisation. The PAS is authored by a steering group representing an equitable spread of stakeholder expertise and opinion. Kanabo Group’s appointment to the steering committee of PAS 13956 will leverage the pioneering experience, research and development of the CBD and cannabis specialist – including extensive clinical and validation activities, as well as safety and efficiency tests conducted by the Group. 

Headquartered in the UK with research and development facilities centred in Israel (an established leader in the cannabis industry) the Pan-European Kanabo Group is focused on developing and commercialising cannabis-derived products for medical patients and wellness CBD consumers. This includes the unique development of high-quality cannabis extract formulas and innovating medical-grade vaporisers and non-combustible inhalation consumption solutions with pharmaceutical grade production standards to produce the highest quality high potency and vegan friendly CBD vape products for consumers. Kanabo Group’s experience and expertise will inform the BSI document to provide a standard specification for the safety, quality and performance of CBD Vape products in order to ensure consumer protection under reasonable and foreseeable conditions based on Kanabo’s own self-regulated standards that include comprehensive safety data, pharmaceutical grade manufacturing practices and stringent product purity testing to ensure no dilutants are used.

Avihu Tamir, CEO Kanabo Group Plc, said: 

“We are delighted to be included within this PAS steering group. We have always taken a safety-first approach to our CDB products and delivery devices, which includes educating consumers about our products and their quality. We always undertake stringent safety and efficacy studies as part of our product development programmes and are unique in the industry in making these results available to the public. These important developments will provide consumers with confidence and ultimately shape the CBD Vape industry.”

Kanabo Group has plans to reach out to the UK Government’s Medicines and Healthcare products Regulatory Agency to highlight the PAS publication and share their standards for testing the safety and efficacy of new products in the hope that the same exacting process and consumer transparency will inform the assessment and establishment of national standards.

Latest news

Akanda Pulls Out Of Lesotho Amid Ongoing Legal Battle, Bruce Linton Joins SynBiotic, & Ananda Completes Acquisition

Akanda The NASDAQ-listed international medical cannabis operator announced last week that it will abandon its operations in Lesotho following...

Concerns Grow As Cannabis Sceptic Appointed To Lead Malta’s Adult-Use Reform

ALMOST one year since passing legislation fears are growing the Maltese Government is set to undermine its commitment to...

Brains Bio Receives NSF’s First CBD Certification For EU GMP CBD API

PRESS RELEASE BRAINS Bioceutical Corp ("Brains Bio" or the "Company"), a global leader in EU GMP grade Cannabidiol (CBD) has...

Amsterdam Cannabis Expo 2022 Latest Scam To Target Industry

AN upcoming European cannabis conference, at which 10,000 cannabis companies were purportedly due to visit, is thought to be...

Juicy Fields Scam May Have Been Small Part Of A Much Larger Criminal Enterprise Says Lawyer As He Prepares To Make Evidence Public

JUICY Fields has already been called the biggest scam in Europe for ‘many, many years’, and its impact on...

Seizure Of 32 Tons Of Cannabis In Spain Was Actually Hemp

BETWEEN telephone calls, Francisco Carbó continues finalising contracts for E-Canna, the hemp processing company he owns based in Valencia,...

Must read

Akanda Pulls Out Of Lesotho Amid Ongoing Legal Battle, Bruce Linton Joins SynBiotic, & Ananda Completes Acquisition

Akanda The NASDAQ-listed international medical cannabis operator announced last...

Concerns Grow As Cannabis Sceptic Appointed To Lead Malta’s Adult-Use Reform

ALMOST one year since passing legislation fears are growing...

You might also likeRELATED
Recommended to you